AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
Focus on painkillers.
Byline: Lewis Krauskopf
Feb. 15--A lot is on the line for pharmaceutical companies, doctors and arthritis patients when a U.S. Food and Drug Administration advisory panel convenes Wednesday.
Over three days, experts will delve into the risks and benefits of widely used painkillers that have come under scrutiny.
The meeting should provide a step toward clarity after the mass confusion sparked by the withdrawal of Vioxx. Merck & Co. Inc. withdrew the pill from the market Sept. 30 because it was linked to an increased risk of heart attacks and strokes. Since then, other studies have led to conflicting information about the cardiovascular safety of two other drugs in Vioxx's class -- Celebrex and Bextra -- and the drug naproxen, which is sold over the counter as Aleve.
At stake this week is how patients will manage arthritis and other types of pain, and…
- Celebrex clear winner after FDA cox-2 committee meeting.(Food and Drug...
- Magazine article from: Drug Store News Johnsen, Michael March 7, 2005 700+ words
...unanimously. Consequently, all cox-2 inhibitors should carry a...to each drug. And none of the cox-2 inhibitors should be directly...majority of members argued. The FDA had promised a fast decision on the future of cox-2s following the recommendations...
- FDA's COX-2 Recommendations Will Benefit Bextra and Celebrex Though Physicians...
- Press release article from: PR Newswire March 23, 2005 700+ words
...PRNewswire/ -- New FDA Advisory Committee Recommendations around COX-2s are likely to...and patients. The FDA's stance that all DTC advertising for COX-2s should be banned...about the marketing of COX-2 Inhibitors. The FDA decided that Celebrex...
- FDA's COX-2 recommendations "will benefit Bextra and Celebex".(United States...
- Newspaper article from: Pharma Marketletter April 4, 2005 700+ words
...started the whole controversy on COX-2s, however, will experience...programs on the outcomes of the FDA's recommendations also could...physicians and patients. The FDA's stance that all DTC [direct-to-consumer] advertising for COX-2s should be banned will make...
- Pfizer To Meet FDA Over COX-2 Rejection.
- News wire article from: The America's Intelligence Wire September 21, 2005 700+ words
...September 2005-Pfizer To Meet FDA Over COX-2 Rejection (C)2005...non-narcotic injectable COX-2 selective analgesic for...it plans to meet with the FDA to discuss the rejection...as the only injectable Cox-2 inhibitor, reduces the...
- FDA Investigates COX-2 Inhibitors.
- News wire article from: The America's Intelligence Wire February 18, 2005 700+ words
...Elizabeth Kaledin DAN RATHER, CBS ANCHOR: FDA experts are out with new recommendations...KALEDIN, CBS CORRESPONDENT: Well, Dan, FDA hearings can be very dry and scientific...doctors tell us that the painkillers known as COX-2 inhibitors cause harm. But in the end...
- FDA recommends limiting COX-2 inhibitors use: an advisory committee should meet...
- Newspaper article from: Drug Formulary Review February 1, 2005 700+ words
...on Dec. 9, the FDA announced that a boxed...valdecoxib (Bextra), a COX-2 inhibitor indicated...NSAIDs, including COX-2 inhibitors. The...data. Here are the FDA's recommendations...be consulted. The FDA says it is collecting...and other data for COX-2 selective and...
- Pharmacology Watch: The FDA Pulls Another COX-2 Inhibitor Off the Market.
- Newspaper article from: Neurology Alert May 1, 2005 700+ words
The FDA Pulls Another COX-2 Inhibitor Off the Market Pharmacology Watch The FDA has asked Pfizer to withdraw valdecoxib...lack of action regarding the risks of COX-2 inhibitors. The FDA stated that Bextra is being withdrawn...
- US FDA panel says COX-2s can be sold, OKs Vioxx' return to market?(United...
- Newspaper article from: Pharma Marketletter February 28, 2005 700+ words
...concerned that new warnings on COX-2s might lead to a migration...presented by drug makers and the FDA. David Graham, associate director...for science and medicine in the FDA's Office of Drug Safety, who...he alleged that high doses of COX-2s posed a danger equal to...
- FDA rejects newest COX-2 blocker.(IN THE NEWS ...)
- Magazine article from: Health News July 1, 2007 700+ words
The FDA rejected Merck & Co.'s request to market a COX-2 blocker etoricoxib (Arcoxia...of osteoarthritis (OA). The FDA's advisory panel had almost unanimously...countries. Arcoxia is the first new COX-2 blocker to come up for approval...
- FDA warns on cox-2 inhibitors, naproxen drug products.(Food and Drug...
- News wire article from: Drug Store News - NewsFirst January 5, 2004 700+ words
...prevention studies that involve the cox-2 selective agents Celebrex...heart attack and stroke. The FDA issued the advisory because recently...clinical trials showing that the cox-2 selective agents may be associated...heart attack and stroke. The FDA also announced that preliminary...
Other Gale sites: Encyclopedia.com | HighBeam Research | Acquire Content | Books & Authors | Goliath | MovieRetriever | Smart QandA
The AccessMyLibrary advertising network includes:
